Use of strong synthetic opioids during surgery linked to poor 'pain experience'
The use of powerful synthetic opioids, such as sufentanil and remifentanil, during surgery is linked to a subsequent poor ...
EXCLUSIVE: Non-Hallucinogenic Psychedelic Compounds Show Promise For Treating Addiction And ADHD
Enveric Biosciences secures a U.S. patent for non-hallucinogenic mescaline derivatives targeting addiction, ADHD and anxiety.
Painkillers don’t work as well for women. Here’s why.
The one-size-fits-all approach to pain management should be a thing of the past. But we’re still not there yet.
Common procedures for chronic spine pain found to offer little to no relief
Researchers from McMaster University and collaborating institutions found that commonly performed interventional procedures ...
The Alternatives to PAIN Act can end the opioid epedemic
Advancements have been made in the pain management field that have successfully found FDA approved alternatives to ...
BioSpace2d
Vertex’s Journavx Changes the Pain Treatment Landscape But Opioids Here to Stay
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...
WRIC2d
FDA approves first opioid-free painkiller in over two decades
The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to ...
JD Supra5d
FDA Approved Journavx, a Non-Opioid Drug for Pain Management
On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...
pulmonologyadvisor6d
FDA Approves First New Non-Opioid Pain Pill in Decades
The US FDA has approved Journavx, a new pain reliever without the risks for addiction or overdose linked to drugs like Vicodin and OxyContin.